Cooperative Study of The Clinical Course of Sickle Cell Disease

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005277
First received: May 25, 2000
Last updated: June 23, 2005
Last verified: August 2004
  Purpose

To determine the natural history of sickle cell disease from birth to death in order to identify those factors contributing to the morbidity and mortality of the disease.


Condition
Anemia, Sickle Cell
Blood Disease

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1977
Estimated Study Completion Date: December 2000
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 25 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Black males and females with sickle cell disease

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005277

Sponsors and Collaborators
Investigators
Investigator: Paul Levy University of Illinois at Chicago
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005277     History of Changes
Other Study ID Numbers: 1500
Study First Received: May 25, 2000
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Anemia, Sickle Cell
Hematologic Diseases
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hemoglobinopathies

ClinicalTrials.gov processed this record on October 22, 2014